A Study to Gather Patient Views on Informed Consent for ALS Trial

Overview

About this study

The purpose of this research study is to capture the views of ALS trial patients on informed consent and their expectations of outcomes of the trial involving stem cells.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Participation will be determined based on Mayo Clinic consultants (Staff, Windebank and Madigan) approaching potential patients to enroll in their ALS Phase 2 trial involving MSC injections prior to undertaking the informed consent procedure. We will attempt to balance participants for gender.

Exclusion Criteria: 

  • None.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Zubin Master, Ph.D.

Contact us for the latest status

Contact information:

Michelle Turner

(507) 284-1223

Turner.Michelle@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available